Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 78 Pages
Report ld: 3944213
Request Sample
Customized Report
Uridine Market Size(US$)

CAGR 2025-2031
7.1%
Market Size,2031
USD 164
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Uridine market size was US$ 102 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Uridine API in this report.
The North America Uridine market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Uridine include BioSpectra, Venkatasai Life Sciences, Tuoxin Pharmaceutical, Meiya Pharmaceutical, Fengchen Group, Aosen New Material Technology Co, Biocompounds Pharmaceutical, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Uridine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Uridine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Uridine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Uridine manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Uridine revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Uridine Product Scope
1.2 Uridine by Type
1.2.1 Global Uridine Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity More Than 99%
1.2.3 Purity More Than 98%
1.2.4 Others
1.3 Uridine by Application
1.3.1 Global Uridine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Fluorouracil Deoxynucleoside
1.3.3 Iodoside
1.3.4 Others
1.4 Global Uridine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Uridine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Uridine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Uridine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Uridine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Uridine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Uridine Sales Market Share by Region (2020-2025)
2.2.2 Global Uridine Revenue Market Share by Region (2020-2025)
2.3 Global Uridine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Uridine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Uridine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Uridine Market Size and Prospective (2020-2031)
2.4.2 Europe Uridine Market Size and Prospective (2020-2031)
2.4.3 China Uridine Market Size and Prospective (2020-2031)
2.4.4 India Uridine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Uridine Historic Market Review by Type (2020-2025)
3.1.1 Global Uridine Sales by Type (2020-2025)
3.1.2 Global Uridine Revenue by Type (2020-2025)
3.1.3 Global Uridine Price by Type (2020-2025)
3.2 Global Uridine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Uridine Sales Forecast by Type (2026-2031)
3.2.2 Global Uridine Revenue Forecast by Type (2026-2031)
3.2.3 Global Uridine Price Forecast by Type (2026-2031)
3.3 Different Types Uridine Representative Players
4 Global Market Size by Application
4.1 Global Uridine Historic Market Review by Application (2020-2025)
4.1.1 Global Uridine Sales by Application (2020-2025)
4.1.2 Global Uridine Revenue by Application (2020-2025)
4.1.3 Global Uridine Price by Application (2020-2025)
4.2 Global Uridine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Uridine Sales Forecast by Application (2026-2031)
4.2.2 Global Uridine Revenue Forecast by Application (2026-2031)
4.2.3 Global Uridine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Uridine Application
5 Competition Landscape by Players
5.1 Global Uridine Sales by Players (2020-2025)
5.2 Global Top Uridine Players by Revenue (2020-2025)
5.3 Global Uridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uridine as of 2024)
5.4 Global Uridine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Uridine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Uridine, Product Type & Application
5.7 Global Key Manufacturers of Uridine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Uridine Sales by Company
6.1.1.1 North America Uridine Sales by Company (2020-2025)
6.1.1.2 North America Uridine Revenue by Company (2020-2025)
6.1.2 North America Uridine Sales Breakdown by Type (2020-2025)
6.1.3 North America Uridine Sales Breakdown by Application (2020-2025)
6.1.4 North America Uridine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Uridine Sales by Company
6.2.1.1 Europe Uridine Sales by Company (2020-2025)
6.2.1.2 Europe Uridine Revenue by Company (2020-2025)
6.2.2 Europe Uridine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Uridine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Uridine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Uridine Sales by Company
6.3.1.1 China Uridine Sales by Company (2020-2025)
6.3.1.2 China Uridine Revenue by Company (2020-2025)
6.3.2 China Uridine Sales Breakdown by Type (2020-2025)
6.3.3 China Uridine Sales Breakdown by Application (2020-2025)
6.3.4 China Uridine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Uridine Sales by Company
6.4.1.1 India Uridine Sales by Company (2020-2025)
6.4.1.2 India Uridine Revenue by Company (2020-2025)
6.4.2 India Uridine Sales Breakdown by Type (2020-2025)
6.4.3 India Uridine Sales Breakdown by Application (2020-2025)
6.4.4 India Uridine Major Customer
6.4.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 BioSpectra
7.1.1 BioSpectra Company Information
7.1.2 BioSpectra Business Overview
7.1.3 BioSpectra Uridine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 BioSpectra Uridine Products Offered
7.1.5 BioSpectra Recent Development
7.2 Venkatasai Life Sciences
7.2.1 Venkatasai Life Sciences Company Information
7.2.2 Venkatasai Life Sciences Business Overview
7.2.3 Venkatasai Life Sciences Uridine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Venkatasai Life Sciences Uridine Products Offered
7.2.5 Venkatasai Life Sciences Recent Development
7.3 Tuoxin Pharmaceutical
7.3.1 Tuoxin Pharmaceutical Company Information
7.3.2 Tuoxin Pharmaceutical Business Overview
7.3.3 Tuoxin Pharmaceutical Uridine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Tuoxin Pharmaceutical Uridine Products Offered
7.3.5 Tuoxin Pharmaceutical Recent Development
7.4 Meiya Pharmaceutical
7.4.1 Meiya Pharmaceutical Company Information
7.4.2 Meiya Pharmaceutical Business Overview
7.4.3 Meiya Pharmaceutical Uridine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Meiya Pharmaceutical Uridine Products Offered
7.4.5 Meiya Pharmaceutical Recent Development
7.5 Fengchen Group
7.5.1 Fengchen Group Company Information
7.5.2 Fengchen Group Business Overview
7.5.3 Fengchen Group Uridine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Fengchen Group Uridine Products Offered
7.5.5 Fengchen Group Recent Development
7.6 Aosen New Material Technology Co
7.6.1 Aosen New Material Technology Co Company Information
7.6.2 Aosen New Material Technology Co Business Overview
7.6.3 Aosen New Material Technology Co Uridine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Aosen New Material Technology Co Uridine Products Offered
7.6.5 Aosen New Material Technology Co Recent Development
7.7 Biocompounds Pharmaceutical
7.7.1 Biocompounds Pharmaceutical Company Information
7.7.2 Biocompounds Pharmaceutical Business Overview
7.7.3 Biocompounds Pharmaceutical Uridine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Biocompounds Pharmaceutical Uridine Products Offered
7.7.5 Biocompounds Pharmaceutical Recent Development
8 Uridine Manufacturing Cost Analysis
8.1 Uridine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Uridine
8.4 Uridine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Uridine Distributors List
9.3 Uridine Customers
10 Uridine Market Dynamics
10.1 Uridine Industry Trends
10.2 Uridine Market Drivers
10.3 Uridine Market Challenges
10.4 Uridine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Uridine was estimated to be worth US$ 109 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 129
USD 3950.00
(Single User License)
The global Uridine market was valued at US$ 109 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 126
USD 2900.00
(Single User License)
The global Uridine market is projected to grow from US$ 102 million in 2024 to US$ 164 million by 2031, at a CAGR of 7.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 145
USD 4900.00
(Single User License)
The global market for Uridine was estimated to be worth US$ 102 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 103
USD 3950.00
(Single User License)
The global market for Uridine was valued at US$ 102 million in the year 2024 and is projected to reach a revised size of US$ 164 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published Date: 2025-02-15
Pages: 89
USD 2900.00
(Single User License)
Uridine API in this report.
Published Date: 2024-04-08
Pages: 97
USD 4900.00
(Single User License)
Uridine API in this report.
Published Date: 2024-02-23
Pages: 99
USD 3950.00
(Single User License)
Uridine API in this report.
Published Date: 2024-01-16
Pages: 87
USD 2900.00
(Single User License)
The global market for Uridine was estimated to be worth US$ 109 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 129
The global Uridine market was valued at US$ 109 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-04-21
Pages: 126
The global Uridine market is projected to grow from US$ 102 million in 2024 to US$ 164 million by 2031, at a CAGR of 7.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 145
The global market for Uridine was estimated to be worth US$ 102 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 103
The global market for Uridine was valued at US$ 102 million in the year 2024 and is projected to reach a revised size of US$ 164 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published: 2025-02-15
Pages: 89
Uridine API in this report.
Published: 2024-04-08
Pages: 97
Uridine API in this report.
Published: 2024-02-23
Pages: 99
Uridine API in this report.
Published: 2024-01-16
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now